Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) Revenue Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 7.78%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 2.63%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 8.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 11.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 16.70%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.08%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 15.05%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 7.41%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 7.29%
10 Xtant Medical Holdings 64.46 Mn 47.14 Mn 17.75 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 19.04%
Jun 30, 2025 18.26%
Mar 31, 2025 18.05%
Dec 31, 2024 12.11%
Sep 30, 2024 11.66%
Jun 30, 2024 48.00%
Mar 31, 2024 55.34%
Dec 31, 2023 84.07%
Sep 30, 2023 73.00%
Jun 30, 2023 32.43%
Mar 31, 2023 38.56%
Dec 31, 2022 9.31%
Sep 30, 2022 5.23%
Jun 30, 2022 2.02%
Mar 31, 2022 3.53%
Dec 31, 2021 -0.32%
Sep 30, 2021 -1.70%
Jun 30, 2021 42.71%
Mar 31, 2021 -15.35%
Dec 31, 2020 -16.57%
Sep 30, 2020 -11.07%
Jun 30, 2020 -30.95%
Mar 31, 2020 -11.65%
Dec 31, 2019 -9.60%
Sep 30, 2019 -8.95%
Jun 30, 2019 -18.53%
Mar 31, 2019 -6.74%
Dec 31, 2018 -32.43%
Sep 30, 2018 -12.75%
Jun 30, 2018 -12.72%
Mar 31, 2018 -18.79%
Dec 31, 2017 10.10%
Sep 30, 2017 -13.61%
Jun 30, 2017 0.28%
Mar 31, 2017 5.27%
Dec 31, 2016 12.22%
Sep 30, 2016 29.47%
Jun 30, 2016 115.43%
Mar 31, 2016 120.74%
Dec 31, 2015 131.38%
Sep 30, 2015 114.56%
Jun 30, 2015 13.51%
Mar 31, 2015 6.62%
Dec 31, 2014 11.29%
Sep 30, 2014 3.99%
Jun 30, 2014 6.32%
Mar 31, 2014 3.41%
Dec 31, 2013 8.23%
Sep 30, 2013 -8.25%
Jun 30, 2013 1.02%
Mar 31, 2013 10.92%
Dec 31, 2012 -12.25%
Sep 30, 2012 14.64%
Jun 30, 2012 10.09%
Mar 31, 2012 32.39%
Dec 31, 2011 78.96%
Sep 30, 2011 86.37%
Jun 30, 2011 130.23%